Marquardt, JU; Thorgeirsson, SS
Stem Cells in Hepatocarcinogenesis: Evidence from Genomic DataSEMINARS IN LIVER DISEASE. Bd. 30. H. 1. 2010 S. 26-34
Zeuzem, S; Asselah, T; Angus, PW et al.
STRONG ANTIVIRAL ACTIVITY AND SAFETY OF IFN-SPARING TREATMENT WITH THE PROTEASE INHIBITOR BI 201335, THE HCV POLYMERASE INHIBITOR BI 207127 AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS CHEPATOLOGY. Bd. 52. H. 4. 2010 S. 876A-877A
Worns, MA; Schuchmann, M; Duber, C et al.
Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib TreatmentONCOLOGY. Bd. 79. H. 1-2. 2010 S. 85-92
Boeker, K; Mauss, S; Zehnter, E et al.
SVR AND ANEMIA IN HCV-GENOTYPE 1 PATIENTS TREATED WITH PEG-INTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV): LITTLE EFFECT OF RIBAVIRIN DOSAGEHEPATOLOGY. Bd. 52. H. 4. 2010 S. 768A-769A
Schattenberg, JM; Lowin, V; Zimmermann, T et al.
THE CASPASE-8 HOMOLOGUE FLIP MODULATES HEPATOCARCINOGENESIS IN MICEJOURNAL OF HEPATOLOGY. Bd. 52. 2010 S. S32-S32
Schuppan, D; Gorrell, MD; Klein, T et al.
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitisLIVER INTERNATIONAL. Bd. 30. H. 6. 2010 S. 795-808
Froldi, F; Ziosi, M; Garoia, F et al.
The lethal giant larvae tumour suppressor mutation requires dMyc oncoprotein to promote clonal malignancyBMC BIOLOGY. Bd. 8. 2010 S. -
Schimanski, C; Mohler, M; Steinbach, A et al.
The Mainz skin protocol: controlling the follicular eruptions rash on cetuximabONKOLOGIE. Bd. 33. 2010 S. 194-194
Waldner, MJ; Neurath, MF
The molecular therapy of colorectal cancerMOLECULAR ASPECTS OF MEDICINE. Bd. 31. H. 2. 2010 S. 171-178
Marker-Hermann, E; Muller-Ladner, U
The mouth, Gingiva, temporomandibular joints and rheumatic diseasesZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 69. H. 2. 2010 S. 107-108